| Index | Ligand Name | Structure | PDB code | ligand desolvation |
| 1 | tol | Human Aldose Reductase complexed with four tolrestat molecules at 1.5 A resolution. | 2fzb | 99.89 |
| 2 | fid | Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution is less than concentration of IDD594. | 2pfh | 96.13 |
| 3 | fid | Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution is equal to concentration of IDD594. | 2pf8 | 96.12 |
| 4 | lit | Human aldose reductase complexed with nitrofuryl-oxadiazol inhibitor at 1.55 A | 2ikh | 95.83 |
| 5 | fid | Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution exceeds concentration of IDD594. | 2pev | 94.84 |
| 6 | ldt | Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution exceeds concentration of IDD594. | 2pev | 94.7 |
| 7 | 2x9 | Complex of Aldose Reductase with inhibitor IDD 1219 | 4gca | 94.63 |
| 8 | ldt | Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution is less than concentration of IDD594. | 2pfh | 94.2 |
| 9 | ldt | Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution is equal to concentration of IDD594. | 2pf8 | 93.85 |
| 10 | id5 | Crystal structure of human aldose reductase complexed with NADP and IDD552 | 1t41 | 93.84 |
| 11 | ldt | Human Aldose Reductase structure | 2r24 | 93.38 |
| 12 | zst | Human Aldose Reductase mutant T113A complexed with Zopolrestat | 3mb9 | 93.11 |
| 13 | zst | Human Aldose Reductase mutant T113S complexed with Zopolrestat | 3len | 93 |
| 14 | bfi | Crystal structure of human Aldose Reductase complexed with NADP and Minalrestat | 1pwl | 92.94 |
| 15 | zst | Human Aldose Reductase mutant T113V in complex with Zopolrestat | 3m0i | 92.83 |
| 16 | 3na | Human aldose reductase in complex with NADP+ and the inhibitor lidorestat at 1.04 angstrom | 1z3n | 92.74 |
| 17 | zst | Human aldose reductase mutant V47I complexed with zopolrestat | 2pd5 | 92.69 |
| 18 | id5 | Crystal structure of human aldose reductase complexed with NADP and IDD552 at ph 5 | 1t40 | 92.56 |
| 19 | 37v | Human Aldose Reductase complexed with a ligand with an IDD structure (2-[2-(1,3-benzothiazol-2-ylmethylcarbamoyl)-5-fluoro-phenoxy]acetic acid) at 1.05 A | 4qr6 | 92.53 |
| 20 | zst | Human Aldose reductase complexed with inhibitor zopolrestat at 1.48 A(1 day soaking). | 2fz8 | 92.42 |
| 21 | zst | Human aldose reductase mutant F121P complexed with zopolrestat. | 2pdb | 92.39 |
| 22 | zst | Crystal structure of human Aldose Reductase complexed with zopolrestat after 3 days soaking (3days_soaked_1) | 2dux | 92.35 |
| 23 | 4o9 | Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(2,6-difluoro-4-iodobenzyl)carbamoyl]phenoxy}acetic acid | 4lbr | 92.33 |
| 24 | zst | Human Aldose Reductase complexed with inhibitor zopolrestat after three days soaking (3days_soaked_3) | 2hv5 | 92.3 |
| 25 | zst | Human Aldose Reductase complexed with inhibitor zopolrestat after six days soaking. | 2fz9 | 92.26 |
| 26 | zst | Human Aldose Reductase-zopolrestat complex obtained by cocrystallisation (10days_cocryst) | 2hvo | 92.17 |
| 27 | zst | Human Aldose Reductase complexed with zopolrestat after 6 days soaking(6days_soaked_2) | 2dv0 | 92.15 |
| 28 | m15 | Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(2-fluoro-4-iodobenzyl)carbamoyl]phenoxy}acetic acid | 4lb3 | 92.14 |
| 29 | 4o8 | Crystal structure of human AR complexed with NADP+ and {2-[(4-bromo-2,6-difluorobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid | 4lbs | 92.13 |
| 30 | zst | Human aldose reductase double mutant S302R-C303D complexed with zopolrestat. | 2pdx | 92.12 |
| 31 | zst | Human Aldose Reductase-zopolrestat complex obtained by cocrystallisation after one day (1day_cocryst) | 2hvn | 92.11 |
| 32 | zst | Human aldose reductase mutant S302R complexed with zopolrestat. | 2pdm | 92.1 |
| 33 | 1wx | Crystal structure of human AR complexed with NADP+ and {2-[(4-bromo-2,3,5,6-tetrafluorobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid | 4lb4 | 92.06 |
| 34 | 30l | Human Aldose Reductase complexed with a ligand with an IDD structure ({5-fluoro-2-[(3-nitrobenzyl)carbamoyl]phenoxy}acetic acid) at 0.98 A | 4qbx | 91.91 |
| 35 | zst | Human Aldose Reductase complexed with inhibitor zopolrestat after 3 days soaking (3days_soaked_2) | 2duz | 91.83 |
| 36 | ldt | Human aldose reductase mutant T113S complexed with IDD594 | 3ld5 | 91.82 |
| 37 | 3t4 | Human aldose reductase in complex with a nitrile-containing IDD inhibitor | 3t42 | 91.76 |
| 38 | ldt | Human Aldose Reductase mutant T113A complexed with IDD 594 | 3lql | 91.73 |
| 39 | ldt | Human aldose reductase mutant T113V complexed with IDD594 | 3lz5 | 91.72 |
| 40 | w8x | Crystal structure of human AR complexed with NADP+ and {2-[(4-bromobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid | 4lau | 91.72 |
| 41 | 1ww | Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(4-iodobenzyl)carbamoyl]phenoxy}acetic acid | 4laz | 91.66 |
| 42 | q74 | Human aldose reductase complexed with IDD 740 inhibitor | 3g5e | 91.59 |
| 43 | 393 | Human aldose reductase mutant S302R complexed with IDD 393. | 2pdp | 91.58 |
| 44 | ldt | Perdeuterated alr2 in complex with idd594 | 2qxw | 91.58 |
| 45 | ldt | Human aldose reductase mutant T113C complexed with IDD594 | 3lbo | 91.56 |
| 46 | ldt | Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effects of radiation damage on protein structure. Forth stage of radiation damage. | 3ghu | 91.49 |
| 47 | 393 | Human aldose reductase mutant T113V complexed with IDD393 | 3m64 | 91.46 |
| 48 | 393 | Human aldose reductase complexed with nitro-substituted IDD-type inhibitor | 2ikj | 91.37 |
| 49 | ldt | Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effects of radiation damage on protein structure. Third stage of radiation damage. | 3ght | 91.36 |
| 50 | ldt | Human aldose reductase in complex with NADP+ and the inhibitor IDD594 at temperature of 15K | 2i16 | 91.36 |
| 51 | 393 | Human Aldose Reductase mutant T113V in complex with IDD393 crystallized in spacegroup P1 | 3mc5 | 91.35 |
| 52 | 393 | Human aldose reductase mutant F121P complexed with IDD393. | 2pdc | 91.34 |
| 53 | ldt | Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effects of radiation damage on protein structure. First stage of radiation damage | 3ghr | 91.32 |
| 54 | i98 | Crystal structure of human AR complexed with NADP+ and AK198 | 4qxi | 91.3 |
| 55 | 393 | Human aldose reductase mutant C303D complexed with IDD393. | 2pdu | 91.27 |
| 56 | 393 | The crystallographic structure of Aldose Reductase IDD393 complex confirms Leu300 as a specificity determinant | 2pzn | 91.27 |
| 57 | ldt | Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effects of radiation damage on protein structure. Second stage of radiation damage. | 3ghs | 91.24 |
| 58 | ldt | Human Aldose Reductase in complex with NADP+ and the inhibitor IDD594 at 0.66 Angstrom | 1us0 | 91.23 |
| 59 | ldt | Human aldose reductase in complex with NADP+ and the inhibitor IDD594 at temperature of 60K | 2i17 | 91.16 |
| 60 | 388 | Human aldose reductase complexed with halogenated IDD-type inhibitor | 2iki | 91.14 |
| 61 | 388 | Human Aldose Reductase mutant T113V complexed with IDD388 | 3m4h | 91.12 |
| 62 | 2yz | Human Aldose Reductase complexed with a ligand with an IDD structure ([2-(benzylcarbamoyl)-5-fluorophenoxy]acetic acid) at 1.19 A | 4q7b | 91.1 |
| 63 | zes | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE INHIBITOR ZENARESTAT. | 1iei | 90.58 |
| 64 | zst | Human aldose reductase mutant L300A complexed with zopolrestat at 1.55 A. | 2pdi | 90.53 |
| 65 | zst | Human aldose reductase mutant L300P complexed with zopolrestat. | 2pdf | 90.47 |
| 66 | tol | Human aldose reductase complexed with tolrestat at 1.08 A resolution. | 2fzd | 89.92 |
| 67 | tol | Human aldose reductase mutant L301M complexed with tolrestat. | 2pdl | 89.63 |
| 68 | 393 | Human aldose reductase mutant L300A complexed with IDD393. | 2pdj | 89.17 |
| 69 | fir | Crystal structure of Aldose Reductase complexed with 2R4S (Stereoisomer of Fidarestat, 2S4S) | 1x97 | 86.67 |
| 70 | doy | Novel Benzothiazepine Inhibitor in Complex with human Aldose Reductase | 3p2v | 86.52 |
| 71 | 3uh | Human Aldose Reductase complexed with a ligand with an IDD structure at 1.20 A (1) | 4rpq | 85.98 |
| 72 | fid | Aldose Reductase Mutant Leu 300 Pro complexed with Fidarestat | 2agt | 85.97 |
| 73 | fid | Human aldose reductase mutant V47I complexed with fidarestat. | 2pd9 | 85.39 |
| 74 | fid | FIDARESTAT BOUND TO HUMAN ALDOSE REDUCTASE | 1ef3 | 85.38 |
| 75 | fid | Human aldose reductase double mutant S302R-C303D complexed with fidarestat. | 2pdy | 85.32 |
| 76 | fid | Human aldose reductase mutant C303D complexed with fidarestat. | 2pdw | 85.31 |
| 77 | fid | Crystal structure of human Aldose Reductase complexed with NADP and Fidarestat | 1pwm | 85.11 |
| 78 | 2wq | Human Aldose Reductase complexed with a ligand with an IDD structure (2-[5-fluoro-2-(prop-2-ynylcarbamoyl)phenoxy]acetic acid) at 1.12 A | 4puw | 84.99 |
| 79 | 2wr | Human Aldose Reductase complexed with a ligand with an IDD structure (2-(2-carbamoyl-5-fluoro-phenoxy)acetic acid) at 1.14 A | 4puu | 84.17 |
| 80 | nti | Aldose reductase complexed with a nitro compound | 3v35 | 82.15 |
| 81 | suz | Aldose reductase in complex with NSAID-type inhibitor at 1.0 A resolution | 3u2c | 81.92 |
| 82 | lpa | Crystal Structure of Aldose Reductase complexed with Lipoic Acid | 2iqd | 81.03 |
| 83 | itb | Human Aldose Reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (2) | 2nvd | 79.98 |
| 84 | av5 | Crystal structure of human AKR1B1 complexed with NADP+ and compound 37 | 5ou0 | 79.47 |
| 85 | ita | Human Aldose Reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (3) | 2nvc | 78.94 |
| 86 | aw8 | Crystal structure of human AKR1B1 complexed with NADP+ and compound 39 | 5ouj | 75.79 |
| 87 | sfi | Crystal Structure of Human Aldose Reductase complexed with Sulindac Sulfide | 3rx4 | 75.33 |
| 88 | avt | Crystal structure of human AKR1B1 complexed with NADP+ and compound 41 | 5ouk | 75.01 |
| 89 | slo | Crystal Structure of Human Aldose Reductase Complexed with Sulindac Sulfone | 3rx2 | 73.61 |
| 90 | suz | Crystal Structure of Human Aldose Reductase Complexed with Sulindac | 3rx3 | 73.48 |
| 91 | 4g7 | Human Aldose Reductase complexed with a ligand with an IDD structure (2) at 1.07 A. | 4ys1 | 68.52 |
| 92 | tlt | Crystal Structure of Human Aldose Reductase Complexed with Tolmetin | 3s3g | 67.09 |
| 93 | wy1 | Human Aldose Reductase in Complex with NADP+ and WY14643 in Space Group P212121 | 5ha7 | 63.91 |
| 94 | i84 | HUMAN ALDOSE REDUCTASE COMPLEXED WITH IDD384 INHIBITOR | 1el3 | 62.74 |